Macrophage ACAT1 Aggravates Alcohol‐Associated Liver Disease by Inducing Mitochondrial Damage and NLRP3 Activation
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Xi Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Macrophages, Liver Diseases, Alcoholic, Acetyl-CoA C-Acetyltransferase. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Shandong Provincial Key Research and Development Program, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Alcohol‐associated liver disease (ALD) is a major cause of advanced liver disease, with limited effective clinical interventions, highlighting an urgent need for new therapeutic targets. Acyl‐CoA:cholesterol acyltransferase 1 (ACAT1) is a key cholesterol‐metabolizing acyltransferase that catalyzes the esterification of free cholesterol into cholesteryl esters. It is highly expressed predominantly in macrophages and participates in the regulation of macrophage functions. Nevertheless, its role and underlying mechanism in alcoholic liver injury remain largely unclear.
Results
We observed that co‐stimulation with ethanol and LPS up‐regulated ACAT1 expression, triggered inflammatory responses in macrophages, and aggravated liver function impairment, lipid deposition, and ROS accumulation in mice, thereby contributing to the progression of ALD. Mechanistically, ACAT1 upregulation induces mitochondrial damage and activates the NLRP3 inflammasome.
Conclusion
ACAT1 is a positive regulatory factor in the inflammatory response of macrophages. It exacerbates ALD by inducing mitochondrial damage and activating NLRP3, providing a theoretical basis for the mechanism by which ACAT1 promotes ALD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
- Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- University Town Hospital, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
- Department of Infectious Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Key Research and Development Program
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhao, X., Peng, S., Zhong, K., Wang, M., Cao, H., Ma, S., Qi, J., Wang, Y., & Zhu, Q. (2026). Macrophage ACAT1 Aggravates Alcohol‐Associated Liver Disease by Inducing Mitochondrial Damage and NLRP3 Activation. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70611
Vancouver
Zhao X, Peng S, Zhong K, Wang M, Cao H, Ma S, et al. Macrophage ACAT1 Aggravates Alcohol‐Associated Liver Disease by Inducing Mitochondrial Damage and NLRP3 Activation. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70611
BibTeX
@article{Zhao2026,
author = {Zhao, Xi and Peng, Shiyu and Zhong, Keqing and Wang, Mingyue and Cao, Huiling and Ma, Shujun and Qi, Jianni and Wang, Yingchun and Zhu, Qiang},
title = {Macrophage ACAT1 Aggravates Alcohol‐Associated Liver Disease by Inducing Mitochondrial Damage and NLRP3 Activation},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70611}
}
EUVIMED